CRC	Colorectal cancer
MIPM	Metastasis–based immune prognostic model
scRNA–seq	Single–cell RNA sequencing
OS	Overall survival
IRGPI	Immune–related gene prognostic index
TIME	Tumor immune microenvironment
ICIs	Immune checkpoint inhibitors
GEO	Gene Expression Omnibus
UMI	Unique molecular identifier
ssGSEA	Single-sample gene set enrichment analysis
HIRG	High–contribution immune-related genes
K-M	Kaplan–Meier
DCA	Decision curve analysis
ROC	Receiver operating characteristic
DFS	Disease–free survival
IC50	Half maximal inhibitory concentration
GDSC	Genomics of Drug Sensitivity in Cancer
TIDE	Tumor immune dysfunction and exclusion
IPS	Immunophenoscore
QC	Quality control
t-SNE	T–distributed stochastic neighbor embedding
AUC	Area under the ROC
CMS	Consensus molecular subtypes
GSVA	Gene set variation analysis
PDOX	Patient-derived organoid–based xenograft
PARP	Poly (ADP–ribose) polymerase
TME	Tumor microenvironment
MSI	Microsatellite instability
MHC	MHC molecules
EC	Effector cells
SC	Suppressor cells
CP	Immune checkpoints
NSCLC	Non-small-cell lung cancer